0001193805-19-000017.txt : 20190102 0001193805-19-000017.hdr.sgml : 20190102 20190102181234 ACCESSION NUMBER: 0001193805-19-000017 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190101 FILED AS OF DATE: 20190102 DATE AS OF CHANGE: 20190102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SASSINE ANDY CENTRAL INDEX KEY: 0001515322 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35932 FILM NUMBER: 19503023 MAIL ADDRESS: STREET 1: 82 DEVONSHIRE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcturus Therapeutics Ltd. CENTRAL INDEX KEY: 0001566049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-900-2660 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: ALCOBRA LTD. DATE OF NAME CHANGE: 20130104 3 1 e618126_3-sassine.xml X0206 3 2019-01-01 0 0001566049 Arcturus Therapeutics Ltd. ARCT 0001515322 SASSINE ANDY C/O ARCTURUS THERAPEUTICS LTD. 10628 SCIENCE CENTER DRIVE, SUITE 250 SAN DIEGO CA 92121 1 1 0 0 Chief Financial Officer Ordinary Shares 237596 D STOCK OPTION (right to purchase) 8.00 2028-08-23 Ordinary Shares 3750 D STOCK OPTION (right to purchase) 8.00 2028-08-23 Ordinary Shares 10000 D STOCK OPTION (right to purchase) 8.00 2018-08-24 2028-08-23 Ordinary Shares 2500 D STOCK OPTION (right to purchase) 8.00 2028-08-23 Ordinary Shares 20000 D STOCK OPTION (right to purchase) 4.53 2028-12-31 Ordinary Shares 100000 D The Reporting Person is filing this form in connection with the Issuer's transition from reporting as a foreign private issuer to reporting as a domestic issuer, effective January 1, 2019. Fully vested as of December 31, 2018. Vesting monthly over a one year period from August 24, 2018. Options to purchase 25,000 shares vest one year from the date of grant and the remainder vests in equal monthly installments over the three year period thereafter. /s/ Andy Sassine 2019-01-02